Cargando…
Significant Reduction in Vertebral Artery Dose by Intensity Modulated Proton Therapy: A Pilot Study for Nasopharyngeal Carcinoma
Intensity modulated proton therapy (IMPT) with the vertebral artery (VA)-sparing technique has been initially proposed in our institution. This pilot study was conducted to compare the dose to VAs between IMPT and volumetric-modulated arc therapy (VMAT) for patients with nasopharyngeal carcinoma (NP...
Autores principales: | Lin, Yun-Hsuan, Cheng, Jen-Yu, Huang, Bing-Shen, Luo, Sheng-Dean, Lin, Wei-Che, Chou, Shang-Yu, Juang, Pei-Jiuan, Li, Shen-Hao, Huang, Eng-Yen, Wang, Yu-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400425/ https://www.ncbi.nlm.nih.gov/pubmed/34442466 http://dx.doi.org/10.3390/jpm11080822 |
Ejemplares similares
-
Feasibility evaluation of N-Isopropyl Acrylamide 3D gel dosimeters for proton therapy
por: Yao, Chun-Hsu, et al.
Publicado: (2023) -
Post-Irradiation Sinus Mucosa Disease in Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Proton Therapy
por: Wu, Pei-Wen, et al.
Publicado: (2022) -
Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy
por: Lin, Yun-Hsuan, et al.
Publicado: (2018) -
Proton versus photon radiotherapy for primary hepatocellular carcinoma: a propensity-matched analysis
por: Cheng, Jen-Yu, et al.
Publicado: (2020) -
Concurrent Sorafenib and Radiotherapy versus Radiotherapy Alone for Locally Advanced Hepatocellular Carcinoma: A Propensity-Matched Analysis
por: Liu, Chieh-Min, et al.
Publicado: (2021)